HP appoints former GSK CEO Emma Walmsley as Chief Executive
Article excerpt
Highlighted: the sentence this signal was extracted from
HP Inc. has appointed former GSK Chief Executive Officer Emma Walmsley as its next CEO, effective January 4, 2027, as the technology company prepares to navigate its next phase of growth amid the expansion of artificial intelligence. The appointment was unanimously approved by HP's Board of Directors, the company said in an announcement on November 4. Walmsley will succeed Bruce Broussard, who has served as interim CEO since February 2026. Broussard will take over as Chair of HP's Board on January 4, 2027, succeeding Chip Bergh, who has held the position since 2017. Walmsley brings experience across GSK and L'Oréal Walmsley served as CEO of global biopharmaceutical company GSK from April 2017 to December 2025. During her tenure, she led a strategic transformation of the business, sharpened its focus on specialty medicines and vaccines, strengthened its research and development pipeline and oversaw the separation of its consumer healthcare business. She joined GSK in 2010 and became CEO of GSK Consumer Healthcare in 2015 before taking over as group CEO. Before joining GSK, Walmsley spent 17 years at L'Oréal, where she held leadership positions across major global consumer businesses. She has also served on Microsoft's Board of Directors for seven years. Commenting on her appointment, Walmsley said HP was an iconic company with an important role in shaping the future of work...
Keep reading with a free account
The rest of this article, and every signal for HP, is in your free account.
